Summary Of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2020

Summary Of Significant Accounting Policies [Abstract]

Summary Of Net Revenue Disaggregated By Product And Region

	Three Months Ended ‎September 30,
	2020		2019
U.S., Canada and Latin America
Devices	$	197,393	$	186,887
Masks and other		205,760		183,441
Total Sleep and Respiratory Care	$	403,153	$	370,328
Software as a Service		92,143		86,855
Total	$	495,296	$	457,183
Combined Europe, Asia and other markets
Devices	$	176,026	$	151,925
Masks and other		80,622		71,948
Total Sleep and Respiratory Care	$	256,648	$	223,873
Global revenue
Devices	$	373,419	$	338,812
Masks and other		286,382		255,389
Total Sleep and Respiratory Care	$	659,801	$	594,201
Software as a Service		92,143		86,855
Total	$	751,944	$	681,056

Summary Of Contract Balances

	September 30, ‎2020		June 30, ‎2020		Balance sheet caption
Contract assets
Accounts receivable, net	$	464,892	$	474,643	Accounts receivable, net
Unbilled revenue, current		9,586		9,452	Prepaid expenses and other current assets
Unbilled revenue, non-current		6,497		6,957	Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current		(102,035)		(98,617)	Deferred revenue (current liabilities)
Deferred revenue, non-current		(83,887)		(87,307)	Deferred revenue (non-current liabilities)

Schedule Of Components Of Lease Revenue

	Three Months Ended ‎September 30,
	2020		2019
Sales-type lease revenue	$	1,960	$	2,258
Operating lease revenue		24,779		21,365
Total lease revenue	$	26,739	$	23,623